BioMed X, a pharmaceutical innovation hub, is partnering with the government of Barbados on research for AI-enabled therapy.

Integrated Biosciences has a new Chief Scientific Officer (CSO), naming Daniel J. Anderson, PhD, to the post. Anderson joins ...

Siegfried, a global CDMO for the pharmaceutical industry, has signed binding agreements with an affiliate of SK Capital ...

To evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing.

Astoriom, a leader in scientific research and consumer product sample stability and biorepository storage, has acquired Precision Stability Storage.

ICON plc is expanding its oncology research capabilities within its Accellacare Site Network through the opening of the Brian Moran Cancer Institute at Duly Health and Care in Illinois.

VoxCell, a Canadian biotechnology company advancing high-resolution, vascularized 3D tissue models, has appointed Graham Craig as Chief Commercial Officer (CCO).

OrganBio, an innovator in intelligent cell manufacturing, has appointed Karol Jarzabek as Chief Operating Officer.

Boehringer Ingelheim and Simcere are developing SIM0709, a pre-clinical bispecific antibody, for treating inflammatory bowel disease (IBD).